Eupraxia Pharmaceuticals (EPRX) Non Operating Income (2023 - 2026)
Eupraxia Pharmaceuticals (EPRX) recorded Non Operating Income of $3.64 million in the quarter ended Jun 30, 2026, compared with -$478,003 a year earlier and up 9.8% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Non Operating Income (2023 - 2026) Analysis & Trends
On a TTM basis, Eupraxia Pharmaceuticals' Non Operating Income came in at $6.92 million as of Jun 30, 2026; for the year ended Dec 31, 2025, it came in at -$152,522.
- Across earlier years, Non Operating Income came in at $1.26 million in the year ended Dec 31, 2024, -$1.08 million in the year ended Dec 31, 2023 and -$1.37 million in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Non Operating Income in data going back to the quarter ended Jun 30, 2023.
- Per Business Quant, the preceding three quarters came in at $3.32 million (quarter ended Mar 31, 2026), -$547,377 (quarter ended Dec 31, 2025) and $513,119 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Eupraxia Pharmaceuticals | 363.60 Mn | 362.00 Mn | - | 3.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.64 Mn |
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | -547,377.00 |
| Sep 30, 2025 | 513,119.00 |
| Jun 30, 2025 | -478,003.00 |
| Mar 31, 2025 | 359,739.00 |
| Dec 31, 2024 | -48,925.00 |
| Sep 30, 2024 | 281,901.00 |
| Jun 30, 2024 | 486,207.00 |
| Dec 31, 2023 | 1.41 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | -3.80 Mn |
API Access
Eupraxia Pharmaceuticals Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();